《異動股》華興資本(01911.HK)急漲18%越百天線成交創五個月高
華興資本控股(01911.HK)價量齊呈異動,股價承今早一舉升破10天及百天線(21.8元及25.3元)勢,下午進一步抽高至26.15元,現造25.65元,急漲18%,一向薄弱成交急至617萬股,爲五個月來最多,涉資1.46億元。
華興上月下旬公佈,截至3月止三個月,融資顧問服務交易金額按年增加4.8倍至180億人民幣(下同),涉及22項融資交易提供諮詢顧問服務;股票承銷交易金額812億元,增加791億元,涉及7筆股票承銷交易。另外,該公司去年純利按年升3.2倍至10.38億元,末期股息按年增1.5倍至0.38元(將於下月5日除淨)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.